Rapid Advanced Sequencing Industry Growth Drives the Global Rare Disease Testing Market

According to MarkNtel Advisors, the Global Rare Disease Testing Market is expected to observe around 9.29% CAGR during 2021-26. The market is driven primarily by the rising patient pool for rare diseases and the surge in big pharmaceutical companies to manufacture rare disease drugs & diagnostic devices.

Get a sample copy of the market research: https://www.marknteladvisors.com/query/request-sample/rare-disease-testing-market.html

Market Report Coverage: Global Rare Disease Testing Market

Market Segmentation
1. By Type (Cardiovascular, Ophthalmological, Neurological, Oncological, Hematological, Endocrine and Metabolism, Gastroenterologist)
2. By Acquisition (Genetic, Externally Acquired)
3. By Technology (Next Generation Sequencing, Complete Genome, Complete Exome, Micro Arrays)
4. By Age Group (0-15 yrs., 16-30 yrs., 31-45 yrs.)
5. By Products (Kits & Assays, Panels)
6. By End User (Hospitals, Diagnostics Laboratories, Clinical Laboratories, Contract Research Organizations)
Region-wise Segmentation
• North America (The US, Canada, Mexico)
• South America (Brazil, Argentina)
• Europe (The UK, Germany, France, Italy, Spain)
• Middle East & Africa (Israel, GCC)
• Asia Pacific (China, India, Japan, Australia, Singapore)

For detailed analysis: https://www.marknteladvisors.com/research-library/rare-disease-testing-market.html

Key Growth Drivers
• mounting awareness levels among people about rare diseases
• commercialization of Complete Genome and Complete Exome Sequencing technologies
• burgeoning patient pool for rare diseases
• massive government funding to encourage research in rare diseases

Market Challenges
• lack of healthcare services
• canceled/postponed appointments resulting in the underdiagnoses of rare disease patients

Market Competitors:

Quest Diagnostics Inc., Centogene N.V., Invitae Corporation., 3billion, Inc., Arup Laboratories., Eurofins Scientific., Strand Life Sciences., Ambry Genetics., Color Genomics, Inc., Health Network Laboratories, PreventionGenetics, Progenity, Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, OPKO Health, Inc.

Share your requirements: https://www.marknteladvisors.com/query/request-customization/rare-disease-testing-market.html

Key Questions Answered in this Report:
1. What are the current & future trends in the Global Rare Disease Testing Market?
2. What are the overall statistics or estimates (Overview, Size- by Value, Forecast Numbers, Segmentation, and Shares) of the Global Rare Disease Testing Market?
3. How has the industry been evolving in terms of geography & service adoption?
4. How has the competition been shaping across the globe, followed by their comparative factorial indexing?
5. What are the key growth drivers & challenges for the Global Rare Disease Testing Market?
6. What are the customer orientation, purchase behavior, and expectations from rare disease testing providers across the globe?
7. What are the region-wise industry size, growth drivers, and challenges?
8. What are the key innovations, opportunities, current & future trends, and regulations in the Global Rare Disease Testing Market?
9. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Rare Disease Testing Market based on a competitive benchmarking matrix?
10. What are the key results derived from the surveys conducted during the Global Rare Disease Testing Market study?

MarkNtel Advisors
1147 88AVE, Delta, British Columbia, BC,V4C,3B8, CANADA
Email: sales@marknteladvisors.com
Tel: +1 604 800 2671
Website: https://www.marknteladvisors.com

About us:
MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.